BIO-4050

N/A

Report date: 2025/01/26 18:38:58
NME

Base Information

Drug NameBIO-4050
Drug Alias NameASK1 inhibitors (Biogen)brain-penetrant apoptosis signal-regulating kinase-1 inhibitors (Biogen)BIO-4050
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis signal-regulating kinase 1 inhibitors
TargetsApoptosis signal-regulating kinase 1
Therapy Area/IndicationsNeuritisAmyotrophic Lateral SclerosisStroke +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen Inc
Inactive CompaniesN/A
Active IndicationsNeuritisAmyotrophic Lateral SclerosisStroke
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A